CD8A and neoplasm: This argument is supported by a recent study, in which the investigators identified not only tumor-specific CD8 TRM cells but also HBV-specific CD8 TRM cells from HCC-infiltrating T cells using peptide-major histocompatibility complex tetramers and single cell RNA sequencing [27].